Provectus Biopharmaceuticals Inc (PVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,301 | -5,505 | -4,337 | -3,014 | -1,162 |
| Depreciation Amortization | 1 | 2 | 1 | 1 | 1 |
| Accounts payable and accrued liabilities | 99 | -390 | 71 | 205 | -363 |
| Other Working Capital | 625 | 892 | 893 | 734 | -260 |
| Other Operating Activity | 219 | 1,676 | 915 | 457 | 690 |
| Operating Cash Flow | $-358 | $-3,326 | $-2,456 | $-1,617 | $-1,093 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | -186 | -152 | N/A |
| Debt Issued | 335 | 2,510 | 1,525 | 995 | 455 |
| Common Stock Issued | 75 | 850 | 700 | 700 | 700 |
| Other Financing Activity | -80 | -273 | 0 | 0 | -82 |
| Financing Cash Flow | $330 | $3,087 | $2,039 | $1,543 | $1,073 |
| Exchange Rate Effect | 0 | 1 | 0 | 0 | 0 |
| Beginning Cash Position | 251 | 490 | 490 | 490 | 490 |
| End Cash Position | 224 | 251 | 73 | 417 | 470 |
| Net Cash Flow | $-27 | $-238 | $-417 | $-73 | $-20 |
| Free Cash Flow | |||||
| Operating Cash Flow | -358 | -3,326 | -2,456 | -1,617 | -1,093 |
| Free Cash Flow | -358 | -3,326 | -2,456 | -1,617 | -1,093 |